Search

Start Over Keyword IMMUNE-RESPONSE

  • PD-1-cis IL-2R agonism yields better effectors from stem-like CD8(+) T cells

    PD-1-cis IL-2R agonism yields better effectors from stem-like CD8(+) T cells
    Authors:Laura Codarri Deak, Roche Innovation Center ZurichValeria Nicolini, Roche Innovation Center ZurichMasao Hashimoto, Emory UniversityMaria Karagianni, Roche Innovation Center ZurichPetra C Schwalie, Roche Innovation Center BaselLaura Lauener, Roche Innovation Center ZurichEleni Maria Varypataki, Roche Innovation Center ZurichMarine Richard, Roche Innovation Center ZurichEsther Bommer, Roche Innovation Center ZurichJohannes Sam, Roche Innovation Center ZurichStefanie Joller, Roche Innovation Center ZurichMario Perro, Roche Innovation Center ZurichFloriana Cremasco, Roche Innovation Center ZurichLeo Kunz, Roche Innovation Center ZurichEmilio Yanguez, Roche Innovation Center ZurichTamara Husser, Roche Innovation Center ZurichRamona Schlenker, Roche Innovation Center ZurichMarisa Mariani, Roche Innovation Center ZurichVinko Tosevski, Roche Innovation Center ZurichSlvia Herter, Roche Innovation Center ZurichMarina Bacac, Roche Innovation Center ZurichInja Waldhauer, Roche Innovation Center ZurichSara Colombetti, Roche Innovation Center ZurichXavier Gueripel, Roche Innovation Center ZurichStephan Wullschleger, Ecole Polytech Fed LausanneMelanie Tichet, Ecole Polytech Fed LausanneDouglas Hanahan, Ecole Polytech Fed LausanneHaydn Kissick, Emory UniversityStephane Leclair, Roche Innovation Center MunichAnne Freimoser-Grundschober, Roche Innovation Center MunichStefan Seeber, Roche Innovation Center MunichVolker Teichgräber, Roche Innovation Center BaselRafi Ahmed, Emory UniversityChristian Klein, Roche Innovation Center ZurichPablo Umaña, Roche Innovation Center Zurich
    Date:2022
    Publisher:NATURE PORTFOLIO
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Metagenomic Shotgun Sequencing of Endocervical, Vaginal, and Rectal Samples among Fijian Women with and without Chlamydia trachomatis Reveals Disparate Microbial Populations and Function across Anatomic Sites: a Pilot Study

    Metagenomic Shotgun Sequencing of Endocervical, Vaginal, and Rectal Samples among Fijian Women with and without Chlamydia trachomatis Reveals Disparate Microbial Populations and Function across Anatomic Sites: a Pilot Study
    Authors:Sankhya Bommana, University of California San FranciscoGracie Richards, University of California San FranciscoMike Kama, Ministry of Health and Medical Services, Suva, FijiReshma Kodimerla, University of California San FranciscoKenan Jijakli, Emory UniversityTimothy Read, Emory UniversityDeborah Dean, University of California San Francisco
    Date:2022
    Publisher:AMER SOC MICROBIOLOGY
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • The Effect of PGC-1alpha-SIRT3 Pathway Activation on Pseudomonas aeruginosa Infection

    The Effect of PGC-1alpha-SIRT3 Pathway Activation on Pseudomonas aeruginosa Infection
    Authors:Nicholas Maurice, Emory UniversityBrahmchetna Bedi, Emory UniversityZhihong Yuan, VA Nebraska Western Iowa Health Care System, OmahaKuo-Chuan Lin, Emory UniversityJoanna Goldberg, Emory UniversityMichael C Hart, Emory UniversityKristina L Bailey, VA Nebraska Western Iowa Health Care System, OmahaRuxana Sadikot, Emory University
    Date:2022
    Publisher:MDPI
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • Vaginal Microbiome Composition in Early Pregnancy and Risk of Spontaneous Preterm and Early Term Birth Among African American Women

    Vaginal Microbiome Composition in Early Pregnancy and Risk of Spontaneous Preterm and Early Term Birth Among African American Women
    Authors:Anne Dunlop, Emory UniversityGlen Satten, Emory UniversityYijuan Hu, Emory UniversityAnna Knight, Emory UniversityCherie Hill, Emory UniversityMichelle L Wright, University of Texas AustinAlicia Smith, Emory UniversityTimothy Read, Emory UniversityBradley Pearce, Emory UniversityElizabeth Corwin, Emory University
    Date:2021
    Publisher:FRONTIERS MEDIA SA
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

    A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
    Authors:Dean Follmann, National Institute of Allergy and Infectious DiseasesJonathan Fintzi, National Institute of Allergy and Infectious DiseasesMichael P Fay, National Institute of Allergy and Infectious DiseasesHolly E Janes, Fred Hutchinson Cancer Research CenterLindsey R Baden, Brigham and Women's HospitaHana M El Sahly, Baylor College of MedicineThomas R Fleming, University of WashingtonDevan V Mehrotra, Merck & Co., IncLindsay N Carpp, Fred Hutchinson Cancer Research CenterMichal Juraska, Fred Hutchinson Cancer Research CenterDavid Benkeser, Emory UniversityDeborah Donnell, Fred Hutchinson Cancer Research CenterYouyi Fong, Fred Hutchinson Cancer Research CenterShu Han, Moderna IncIan Hirsch, AstraZenecaYing Huang, Fred Hutchinson Cancer Research Center, SeattleYunda Huang, Fred Hutchinson Cancer Research Center, SeattleOlivier Hyrien, Fred Hutchinson Cancer Research Center, SeattleAlex Luedtke, University of WashingtonMarco Carone, University of WashingtonMartha Nason, National Institute of Allergy and Infectious Diseases, BethesdaAn Vandebosch, Janssen Pharmaceut NVHonghong Zhou, Moderna IncIksung Cho, Novavax IncErin Gabriel, Karolinska InstitutetJames G Kublin, Fred Hutchinson Cancer Research Center, SeattleMyron S Cohen, University of North CarolinaLawrence Corey, Fred Hutchinson Cancer Research CenterPeter B Gilbert, Fred Hutchinson Cancer Research CenterKathleen M Neuzil, University of Maryland
    Date:2021
    Publisher:AMER COLL PHYSICIANS
    Publication Version:Final Published Version

  • Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway

    Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway
    Authors:Seema Patel, Emory UniversityTaran S Lundgren, Emory UniversityWallace H Baldwin, Emory UniversityCourtney Cox, Emory UniversityErnest T Parker, Emory UniversityJohn F Healey, Emory UniversityRyan P Jajosky, Harvard Medical SchoolPatricia Zerra, Emory UniversityCassandra Josephson, Emory UniversityChristopher Doering, Emory UniversitySean Stowell, Emory UniversityShannon Meeks, Emory University
    Date:2022
    Publisher:FRONTIERS MEDIA SA
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • The 3.2 angstrom structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain

    The 3.2 angstrom structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain
    Authors:Ian W. Smith, Western Washington UniversityAnne E. d'Aquino, Western Washington UniversityChristopher W. Coyle, Emory UniversityAndrew Fedanov, Emory UniversityErnest T. Parker, Emory UniversityGabriela Denning, Expression Therapeutics, LLC.H Trent Spencer, Emory UniversityJohn Lollar, Emory UniversityChristopher Doering, Emory UniversityP. Clint Spiegel. Jr., Western Washington University
    Date:2019
    Publisher:WILEY
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Posttraumatic Stress Disorder and Incident Infections A Nationwide Cohort Study

    Posttraumatic Stress Disorder and Incident Infections A Nationwide Cohort Study
    Authors:Tammy Jiang, Boston UniversityDora Kormendine Farkas, Aarhus UniversityThomas P. Ahern, University of VermontTimothy Lash, Emory UniversityHenrik T. Sorensen, Boston UniversityJaimie L. Gradus, Boston University
    Date:2019
    Publisher:LIPPINCOTT WILLIAMS & WILKINS
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial 4.0 International

  • Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019

    Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
    Authors:William A. Bower, Emory UniversityJarad Schiffer, Centers for Disease Control and PreventionRobert L. Atmar, Baylor College of MedicineWendy A. Keitel, Baylor College of MedicineArthur M. Friedlander, US Army Medical Research InstituteLindy Liu, Centers for Disease Control and PreventionYon Yu, Centers for Disease Control and PreventionDavid Stephens, Emory UniversityConrad P. Quinn, Centers for Disease Control and PreventionKatherine Hendricks, Centers for Disease Control and Prevention
    Date:2019
    Publisher:CENTERS DISEASE CONTROL & PREVENTION
    Publication Version:Final Published Version

  • Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese

    Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese
    Authors:Jihu Lu, Jiangsu Academy of Agricultural SciencesPeipei Wu, Jiangsu Academy of Agricultural SciencesXuehua Zhang, Jiangsu Academy of Agricultural SciencesLei Feng, Jiangsu Academy of Agricultural SciencesBin Dong, Jiangsu Academy of Agricultural SciencesXuan Chu, Jiangsu Academy of Agricultural SciencesXiufan Liu, Yangzhou UniversityDaxin Peng, Yangzhou UniversityYuan Liu, Emory UniversityHuailiang Ma, Emory UniversityJibo Hou, Jiangsu Academy of Agricultural SciencesYinghua Tang, Jiangsu Academy of Agricultural Sciences
    Date:2016
    Publisher:PUBLIC LIBRARY SCIENCE
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International